Pharmacon Limited
Pharmacon Limited, a leading name in the pharmaceutical industry, is headquartered in Bangladesh (BD) and operates extensively across South Asia. Founded in 2001, the company has established itself as a key player in the development and manufacturing of high-quality generic medicines and active pharmaceutical ingredients (APIs). Pharmacon Limited is renowned for its commitment to innovation and quality, offering a diverse range of products that cater to various therapeutic areas, including cardiology, oncology, and infectious diseases. The company’s state-of-the-art facilities and adherence to international regulatory standards set it apart in a competitive market. With a strong focus on research and development, Pharmacon Limited has achieved significant milestones, positioning itself as a trusted partner in healthcare. Its dedication to excellence has earned recognition both locally and internationally, solidifying its reputation as a reliable source of pharmaceutical solutions.
DitchCarbon Score
How does Pharmacon Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmacon Limited's score of 0 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmacon Limited's reported carbon emissions
Pharmacon Limited, headquartered in Bangladesh (BD), currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions statistics, it is important to note that Pharmacon Limited has not outlined any specific reduction targets or climate commitments. This lack of publicly available information may reflect a broader industry context where many companies are still in the early stages of formalising their climate strategies. As the global focus on sustainability intensifies, it is crucial for companies like Pharmacon Limited to establish clear climate commitments and reduction initiatives to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmacon Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
